Cargando…
Corrigendum: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761765/ https://www.ncbi.nlm.nih.gov/pubmed/36545015 http://dx.doi.org/10.3389/fcvm.2022.1076420 |
| _version_ | 1784852744277852160 |
|---|---|
| author | Chen, Hongjie Chen, Jiepeng Zhang, Fuping Li, Yuanhui Wang, Ronghua Zheng, Qiang Zhang, Xu Zeng, Jun Xu, Feng Lin, Yiguang |
| author_facet | Chen, Hongjie Chen, Jiepeng Zhang, Fuping Li, Yuanhui Wang, Ronghua Zheng, Qiang Zhang, Xu Zeng, Jun Xu, Feng Lin, Yiguang |
| author_sort | Chen, Hongjie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9761765 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97617652022-12-20 Corrigendum: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants Chen, Hongjie Chen, Jiepeng Zhang, Fuping Li, Yuanhui Wang, Ronghua Zheng, Qiang Zhang, Xu Zeng, Jun Xu, Feng Lin, Yiguang Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2022-12-05 /pmc/articles/PMC9761765/ /pubmed/36545015 http://dx.doi.org/10.3389/fcvm.2022.1076420 Text en Copyright © 2022 Chen, Chen, Zhang, Li, Wang, Zheng, Zhang, Zeng, Xu and Lin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Cardiovascular Medicine Chen, Hongjie Chen, Jiepeng Zhang, Fuping Li, Yuanhui Wang, Ronghua Zheng, Qiang Zhang, Xu Zeng, Jun Xu, Feng Lin, Yiguang Corrigendum: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants |
| title | Corrigendum: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants |
| title_full | Corrigendum: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants |
| title_fullStr | Corrigendum: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants |
| title_full_unstemmed | Corrigendum: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants |
| title_short | Corrigendum: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants |
| title_sort | corrigendum: effective management of atherosclerosis progress and hyperlipidemia with nattokinase: a clinical study with 1,062 participants |
| topic | Cardiovascular Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761765/ https://www.ncbi.nlm.nih.gov/pubmed/36545015 http://dx.doi.org/10.3389/fcvm.2022.1076420 |
| work_keys_str_mv | AT chenhongjie corrigendumeffectivemanagementofatherosclerosisprogressandhyperlipidemiawithnattokinaseaclinicalstudywith1062participants AT chenjiepeng corrigendumeffectivemanagementofatherosclerosisprogressandhyperlipidemiawithnattokinaseaclinicalstudywith1062participants AT zhangfuping corrigendumeffectivemanagementofatherosclerosisprogressandhyperlipidemiawithnattokinaseaclinicalstudywith1062participants AT liyuanhui corrigendumeffectivemanagementofatherosclerosisprogressandhyperlipidemiawithnattokinaseaclinicalstudywith1062participants AT wangronghua corrigendumeffectivemanagementofatherosclerosisprogressandhyperlipidemiawithnattokinaseaclinicalstudywith1062participants AT zhengqiang corrigendumeffectivemanagementofatherosclerosisprogressandhyperlipidemiawithnattokinaseaclinicalstudywith1062participants AT zhangxu corrigendumeffectivemanagementofatherosclerosisprogressandhyperlipidemiawithnattokinaseaclinicalstudywith1062participants AT zengjun corrigendumeffectivemanagementofatherosclerosisprogressandhyperlipidemiawithnattokinaseaclinicalstudywith1062participants AT xufeng corrigendumeffectivemanagementofatherosclerosisprogressandhyperlipidemiawithnattokinaseaclinicalstudywith1062participants AT linyiguang corrigendumeffectivemanagementofatherosclerosisprogressandhyperlipidemiawithnattokinaseaclinicalstudywith1062participants |